Literature DB >> 25419694

TLI-based reduced-intensity conditioning hematopoietic SCT for children and adolescents with high-risk nonmalignant disorders.

A A Hussein1, A Al-Mousa2, E Khattab1, A Al-Zaben1, H Frangoul3.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25419694     DOI： 10.1038/bmt.2014.268

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders.

Authors:  S Shenoy; W J Grossman; J DiPersio; L C Yu; D Wilson; Y J Barnes; T Mohanakumar; A Rao; R J Hayashi
Journal:  Bone Marrow Transplant       Date:  2005-02       Impact factor: 5.483

2.  Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction.

Authors:  A Kikuta; M Ito; K Mochizuki; M Akaihata; K Nemoto; H Sano; H Ohto
Journal:  Bone Marrow Transplant       Date:  2006-10-02       Impact factor: 5.483

3.  Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin.

Authors:  J T Horan; J L Liesveld; P Fenton; N Blumberg; M C Walters
Journal:  Bone Marrow Transplant       Date:  2005-01       Impact factor: 5.483

4.  Engraftment and survival following hematopoietic stem cell transplantation for osteopetrosis using a reduced intensity conditioning regimen.

Authors:  J Tolar; C Bonfim; S Grewal; P Orchard
Journal:  Bone Marrow Transplant       Date:  2006-11-06       Impact factor: 5.483

5.  Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease.

Authors:  Mark C Walters; Karen Hardy; Sandie Edwards; Thomas Adamkiewicz; James Barkovich; Francoise Bernaudin; George R Buchanan; Nancy Bunin; Roswitha Dickerhoff; Roger Giller; Paul R Haut; John Horan; Lewis L Hsu; Naynesh Kamani; John E Levine; David Margolis; Kwaku Ohene-Frempong; Melinda Patience; Rupa Redding-Lallinger; Irene A G Roberts; Zora R Rogers; Jean E Sanders; J Paul Scott; Keith M Sullivan
Journal:  Biol Blood Marrow Transplant       Date:  2009-10-12       Impact factor: 5.742

6.  Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease.

Authors:  Lakshmanan Krishnamurti; Sandhya Kharbanda; Melinda A Biernacki; Wandi Zhang; K Scott Baker; John E Wagner; Catherine J Wu
Journal:  Biol Blood Marrow Transplant       Date:  2008-11       Impact factor: 5.742

7.  Bone marrow transplantation in patients with thalassemia.

Authors:  G Lucarelli; M Galimberti; P Polchi; E Angelucci; D Baronciani; C Giardini; P Politi; S M Durazzi; P Muretto; F Albertini
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

8.  Paediatric allogeneic bone marrow transplantation for homozygous beta-thalassaemia, the Dutch experience.

Authors:  L M Ball; A C Lankester; P C Giordano; M H van Weel; C L Harteveld; R G M Bredius; F J Smiers; R M Egeler; J M J J Vossen
Journal:  Bone Marrow Transplant       Date:  2003-06       Impact factor: 5.483

9.  Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen.

Authors:  I B Resnick; M Aker; P Tsirigotis; M Y Shapira; A Abdul-Hai; M Bitan; B Gesundheit; A Amar; A Ackerstein; S Samuel; S Slavin; R Or
Journal:  Bone Marrow Transplant       Date:  2007-09-10       Impact factor: 5.483

10.  Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin.

Authors:  Lauren Veltri; Michael Regier; Aaron Cumpston; Sonia Leadmon; William Tse; Michael Craig; Mehdi Hamadani
Journal:  Bone Marrow Res       Date:  2013-04-17
  10 in total
  1 in total

Review 1.  Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review.

Authors:  Olga Mulas; Brunella Mola; Giovanni Caocci; Giorgio La Nasa
Journal:  J Clin Med       Date:  2022-02-09       Impact factor: 4.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.